PURDUE PHARMA L.P.
Patent Owner
Stats
- 463 US PATENTS IN FORCE
- 53 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 463 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 32,332 Total Citation Count
- Jul 18, 1986 Earliest Filing
- 179 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0022,786 NOVEL SODIUM CHANNEL BLOCKING PEPTIDES AND THE USE THEREOFJul 14, 17Jan 25, 18[A61K, C07K]
2017/0246,194 Acetaminophen-Containing Analgesic Formulations With Reduced HepatotoxicityAug 14, 15Aug 31, 17[A61K]
2017/0231,978 MATRIX FOR SUSTAINED, INVARIANT AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDSApr 28, 17Aug 17, 17[A61K]
2017/0233,400 METHODS FOR MAKING 3-O-PROTECTED MORPHINONES AND 3-O-PROTECTED MORPHINONE DIENOL CARBOXYLATESMay 04, 17Aug 17, 17[C07D]
2017/0224,676 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINEApr 27, 17Aug 10, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9902726 Pyridone-sulfone morphinan analogs as opioid receptor ligandsSep 12, 14Feb 27, 18[A61K, C07D, C07B]
9890164 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsSep 18, 15Feb 13, 18[C07D]
9884059 Systems and methods for treating an opioid-induced adverse pharmacodynamic responseMar 26, 15Feb 06, 18[A61K]
9878991 TRPV1 antagonists including dihydroxy substituent and uses thereofJun 10, 16Jan 30, 18[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0175,447 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINEAbandonedFeb 25, 16Jun 23, 16[A61K, A61M]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
